Myelotoxicity and Dose Intensity of Chemotherapy: Reporting Practices From Randomized Clinical Trials

Author： Dale David C. McCarter Gordon C. Crawford Jeffrey Lyman Gary H.

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.1, Iss.3, 2003-07, pp. : 440-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of: “Randomized Clinical Trials: Design, Practice and Reporting, by D. Machin and P. M. Fayers”

By Assaid Christopher

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 2, 2011-03 ,pp. : 367-370

Taylor & Francis Ltd

Access to resources Recommend Favorite

ADE reporting in clinical trials lacking

Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Clinical trials of chemotherapy for falciparum malaria

By Winstanley P. Olliaro P.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 2, 1998-02 ,pp. : 261-271

Informa Healthcare

Access to resources Recommend Favorite

Randomized Phase II Clinical Trials

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 4, 2014-07 ,pp. : 802-816

Taylor & Francis Ltd

Access to resources Recommend Favorite

Impact of Chemotherapy Dose Intensity on Cancer Patient Outcomes

By Lyman Gary H.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 1, 2009-01 ,pp. : 99-108

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite